Search Results - "Borson, Steven"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Mammalian Target of Rapamycin (mTOR) Activation Increases Axonal Growth Capacity of Injured Peripheral Nerves by Abe, Namiko, Borson, Steven H., Gambello, Michael J., Wang, Fan, Cavalli, Valeria

    Published in The Journal of biological chemistry (03-09-2010)
    “…Unlike neurons in the central nervous system (CNS), injured neurons in the peripheral nervous system (PNS) can regenerate their axons and reinnervate their…”
    Get full text
    Journal Article
  2. 2

    Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck by Hsieh, Ronan W., Borson, Steven, Tsagianni, Anastasia, Zandberg, Dan P.

    Published in Frontiers in oncology (01-09-2021)
    “…Head and neck cancer is the 6 th most common cancer worldwide with the most common histology being squamous cell carcinoma (HNSCC). While the majority of…”
    Get full text
    Journal Article
  3. 3

    Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT by Badar, Talha, Epperla, Narendranath, Szabo, Aniko, Borson, Steven, Vaughn, John, George, Gemlyn, Saini, Neeraj, Shah, Abdul Rashid, Patel, Romil D., Ahmed, Sairah, Shah, Nirav N., Cashen, Amanda F., Hamadani, Mehdi, Fenske, Timothy S.

    Published in Blood advances (14-01-2020)
    “…Patients with classic Hodgkin lymphoma (cHL) who relapse after autologous hematopoietic cell transplantation (auto-HCT) historically have had poor outcomes. We…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Trends in Post-Relapse Survival in Classical Hodgkin Lymphoma Patients after Experiencing Therapy Failure Following Autologous Hematopoietic Cell Transplantation by Badar, Talha, Epperla, Narendranath, Szabo, Aniko, Borson, Steven, Vaughn, John, George, Gemlyn, Shah, Nirav N, Cashen, Amanda F, Hamadani, Mehdi, Fenske, Timothy S.

    Published in Blood (29-11-2018)
    “…Background Classical Hodgkin Lymphoma (cHL) is a highly curable disease; however, 10% of patients (pts) with limited stage and 20%-30% with advanced stage…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Graft Lymphocyte Content Does Not Influence Outcomes after Peripheral Blood Haploidentical Transplants Using Post Transplant Cyclophosphamide (PTCy) by Borson, Steven H, Slade, Michael, DiPersio, John F, Westervelt, Peter, Schroeder, Mark A., Romee, Rizwan, Jensen, Cory

    Published in Blood (02-12-2016)
    “…Background: The best results for allogeneic hematopoietic cell transplants (HCT) remain with HLA-matched sibling donors. Unfortunately, these donors are only…”
    Get full text
    Journal Article